Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Dietel

Showing results (111-120 of 286) with videos related to

Pageof 29
Sort By:
Virchows Archiv : an International Journal of Pathology|November 23, 2015
TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomyKasper Drimer Berg, Davide Soldini, Maria Jung, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2006
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosisFlorian R Fritzsche, Monika Jung, Chuanliang Xu, et al.
Cancer|February 29, 2008
Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancerAurelia Noske, Wilko Weichert, Silvia Niesporek, et al.
Histopathology|June 16, 2010
Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue markerVerena Tischler, Florian R Fritzsche, Josefine Gerhardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcomePawel Surowiak, Verena Materna, Irina Kaplenko, et al.
Gynecologic Oncology|January 2, 2016
Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinomaEliane Tabea Taube, Carsten Denkert, Jalid Sehouli, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomasWilko Weichert, Carsten Denkert, Aurelia Noske, et al.
Histopathology|November 19, 2011
Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissueBruno V Sinn, Silvia Darb-Esfahani, Ralph M Wirtz, et al.
International Journal of Cancer|November 15, 2002
Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinomaCarsten Denkert, Wolfgang D Schmitt, Stefan Berger, et al.
Human Pathology|March 9, 2012
Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancerAlbrecht Stenzinger, Moritz von Winterfeld, Anja Rabien, et al.
Pageof 29

Showing results (111-120 of 286) with videos related to

Sort By:
Pageof 29
Virchows Archiv : an International Journal of Pathology|November 23, 2015
TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomyKasper Drimer Berg, Davide Soldini, Maria Jung, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2006
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosisFlorian R Fritzsche, Monika Jung, Chuanliang Xu, et al.
Cancer|February 29, 2008
Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancerAurelia Noske, Wilko Weichert, Silvia Niesporek, et al.
Histopathology|June 16, 2010
Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue markerVerena Tischler, Florian R Fritzsche, Josefine Gerhardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcomePawel Surowiak, Verena Materna, Irina Kaplenko, et al.
Gynecologic Oncology|January 2, 2016
Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinomaEliane Tabea Taube, Carsten Denkert, Jalid Sehouli, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomasWilko Weichert, Carsten Denkert, Aurelia Noske, et al.
Histopathology|November 19, 2011
Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissueBruno V Sinn, Silvia Darb-Esfahani, Ralph M Wirtz, et al.
International Journal of Cancer|November 15, 2002
Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinomaCarsten Denkert, Wolfgang D Schmitt, Stefan Berger, et al.
Human Pathology|March 9, 2012
Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancerAlbrecht Stenzinger, Moritz von Winterfeld, Anja Rabien, et al.
Pageof 29